The hepatic safety profile of duloxetine: a review

Author： McIntyre Roger S   Panjwani Zilomi D   Nguyen Ha T   Woldeyohannes Hanna O   Alsuwaidan Mohammad   Soczynska Joanna K   Lourenco Maria T   Konarski Jakub Z   Kennedy Sidney H  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.4, Iss.3, 2008-03, pp. : 281-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and adverse event profile of duloxetine

By Wernicke Joachim F   Gahimer James   Yalcin Ilker   Wulster-Radcliffe Meghan   Viktrup Lars  

Expert Opinion on Drug Safety, Vol. 4, Iss. 6, 2005-11 ,pp. : 987-993

Informa Healthcare

Access to resources Recommend Favorite

Vildagliptin shows good hepatic/pancreatic safety profile

By  

Reactions Weekly, Vol. 1, Iss. 1278, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

An Evaluation of the Cardiovascular Safety Profile of Duloxetine: Findings from 42 Placebo-Controlled Studies

By Wernicke Joachim  

Drug Safety, Vol. 30, Iss. 5, 2007-01 ,pp. : 437-455

Adis International

Access to resources Recommend Favorite

The Dual Transporter Inhibitor Duloxetine: A Review of its Preclinical Pharmacology, Pharmacokinetic Profile, and Clinical Results in Depression

By  

Current Pharmaceutical Design, Vol. 11, Iss. 12, 2005-05 ,pp. : 1475-1493

Bentham Science Publishers

Access to resources Recommend Favorite

The General and Comparative Efficacy and Safety of Duloxetine in Major Depressive Disorder: A Systematic Review and Meta-Analysis

By Gartlehner Gerald   Thaler Kylie  

Drug Safety, Vol. 32, Iss. 12, 2009-12 ,pp. : 1159-1173

Adis International

Access to resources Recommend Favorite